Comment on: 'A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance'

摘要

I read with interest the work of Mott et al., published in Applied Health Economics and Health Policy in 2020 1. In this publication, the authors conclude that "Patients in different European countries do not have the same preferences for the attributes of diagnostic tests to manage antimicrobial resistance (AMR) in primary care."In this respect, and in respect to the comment "Considering patient preferences when designing diagnostic tests is important because individuals' preferences could directly influence their uptake of such tests, yet to date no studies have explored this issue.", I would like to draw the authors' attention to an article published on a related theme from 2013, namely "Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public" 2, which was part of a European Union (EU)-funded FP7 project (TEMPOtest-QC—Grant agreement ID 241742) 3. I would also like to draw on my own (albeit non-economics-based) experience in this area 4-7.